J. Harting

649 total citations
23 papers, 540 citations indexed

About

J. Harting is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, J. Harting has authored 23 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in J. Harting's work include Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). J. Harting is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). J. Harting collaborates with scholars based in Germany, United States and Netherlands. J. Harting's co-authors include Hartmut E. Greiner, Christoph A. Seyfried, Andrew Barber, Gerd D. Bartoszyk, Klaus-Otto Minck, D. E. McMillan, Rudolf Gottschlich, Henning Böttcher, Frank Mauler and Robert Murray and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

J. Harting

22 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Harting Germany 14 206 201 109 85 58 23 540
M Gerold Switzerland 12 200 1.0× 208 1.0× 158 1.4× 171 2.0× 60 1.0× 34 638
J.R. Boissier France 10 297 1.4× 326 1.6× 117 1.1× 171 2.0× 78 1.3× 16 788
Ronald D. Robson Switzerland 15 221 1.1× 178 0.9× 102 0.9× 143 1.7× 74 1.3× 33 575
F Lefèvre-Borg France 18 398 1.9× 300 1.5× 193 1.8× 170 2.0× 64 1.1× 28 821
Charles A. Harrington United States 13 207 1.0× 132 0.7× 72 0.7× 26 0.3× 91 1.6× 26 632
A. Pinelli Italy 12 132 0.6× 80 0.4× 66 0.6× 59 0.7× 45 0.8× 66 434
Rodolfo Testa Italy 15 280 1.4× 182 0.9× 117 1.1× 74 0.9× 61 1.1× 34 617
Irwin H. Slater United States 12 229 1.1× 197 1.0× 92 0.8× 90 1.1× 92 1.6× 23 654
H Schmitt France 11 235 1.1× 237 1.2× 200 1.8× 113 1.3× 52 0.9× 21 567
G. Kroneberg Germany 15 304 1.5× 206 1.0× 153 1.4× 136 1.6× 85 1.5× 67 790

Countries citing papers authored by J. Harting

Since Specialization
Citations

This map shows the geographic impact of J. Harting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Harting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Harting more than expected).

Fields of papers citing papers by J. Harting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Harting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Harting. The network helps show where J. Harting may publish in the future.

Co-authorship network of co-authors of J. Harting

This figure shows the co-authorship network connecting the top 25 collaborators of J. Harting. A scholar is included among the top collaborators of J. Harting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Harting. J. Harting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Böttcher, Henning, J. Harting, Hartmut E. Greiner, et al.. (2000). New Selective and Potent 5-HT1B/1DAntagonists:  Chemistry and Pharmacological Evaluation ofN-Piperazinylphenyl Biphenylcarboxamides and Biphenylsulfonamides. Journal of Medicinal Chemistry. 43(3). 517–525. 18 indexed citations
2.
Amsterdam, Christoph van, et al.. (2000). 5-HT Reuptake Inhibitors with 5-HT1B/1DAntagonistic Activity:  A New Approach toward Efficient Antidepressants. Journal of Medicinal Chemistry. 43(6). 1149–1157. 54 indexed citations
3.
Barber, Andrew, et al.. (1999). Effects of GR-89696 and the novel peripherally selective OP2agonists, EMD-61569 and EMD-61747, against focal cerebral ischemiain the rat. Methods and Findings in Experimental and Clinical Pharmacology. 21(2). 105–105. 3 indexed citations
4.
Koch, Michael, Alexandra Montkowski, Marike Lancel, et al.. (1999). Assessment of neuroleptic-like properties of progesterone. Psychopharmacology. 143(1). 29–38. 56 indexed citations
5.
Bartoszyk, Gerd D., J. Harting, & Klaus-Otto Minck. (1996). Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 41–48. 10 indexed citations
6.
Hölzemann, Günter, et al.. (1994). Cyclic hexapeptide NK‐2 antagonists. International journal of peptide & protein research. 44(2). 105–111. 4 indexed citations
7.
Barber, Andrew, Gerd D. Bartoszyk, Hartmut E. Greiner, et al.. (1994). Central and peripheral actions of the novel κ‐opioid receptor agonist, EMD 60400. British Journal of Pharmacology. 111(3). 843–851. 15 indexed citations
8.
Barber, Andrew, Gerd D. Bartoszyk, Rudolf Gottschlich, et al.. (1994). A pharmacological profile of the novel, peripherally‐selectivek‐opioid receptor agonist, EMD 61753. British Journal of Pharmacology. 113(4). 1317–1327. 109 indexed citations
9.
Hölzemann, Günter, Hartmut E. Greiner, J. Harting, Gerhard Barnickel, & Anna Seelig. (1993). Do substance P agonists insert into the lipid membrane?. Regulatory Peptides. 46(1-2). 453–454. 1 indexed citations
10.
Wollborn, Ute, Roger M. Brunne, J. Harting, Günter Hölzemann, & Dieter Leibfritz. (1993). Comparative conformational analysis and in vitro pharmacological evaluation of three cyclic hexapeptide NK‐2 antagonists. International journal of peptide & protein research. 41(4). 376–384. 10 indexed citations
11.
Wienrich, M., et al.. (1989). Effects of receptor‐selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture. British Journal of Pharmacology. 98(3). 914–920. 4 indexed citations
12.
13.
Lues, Inge, et al.. (1988). Effect of isomazole on the responsiveness to calcium of the contractile elements in skinned cardiac muscle fibres of various species. European Journal of Pharmacology. 146(1). 145–153. 23 indexed citations
14.
Harting, J., et al.. (1986). Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.. PubMed. 36(2). 200–8. 23 indexed citations
15.
Schulze, Ernst‐Detlef, et al.. (1986). Antagonistic effects of bisoprolol on several β-adrenoceptor-mediated actions in anaesthetized cats. European Journal of Pharmacology. 123(2). 253–261. 7 indexed citations
16.
Fuchs, Andreas, et al.. (1986). Avoidance Acquisition in Adult and Senescent Rats. Gerontology. 32(2). 91–97. 17 indexed citations
17.
Haeusler, G., P. Schelling, K Becker, et al.. (1985). High β1-Selectivity and Favourable Pharmacokinetics as the Outstanding Properties of Bisoprolol. Journal of Cardiovascular Pharmacology. 8. S2–S15. 33 indexed citations
18.
Harting, J., et al.. (1984). β1-Selectivity of Bisoprolol, a New β-Adrenoceptor Antagonist, in Anesthetized Dogs and Guinea Pigs. Journal of Cardiovascular Pharmacology. 6(6). 1156–1160. 44 indexed citations
19.
Harting, J. & D. E. McMillan. (1976). Repeated Acquisition of Response Sequences by Pigeons Under Chained and Tandem Schedules with Reset and Non-Reset Contingencies. The Psychological Record. 26(3). 361–367. 6 indexed citations
20.
Kraft, H.G. & J. Harting. (1969). BIOLOGICAL PROPERTIES OF ST C 407, A NEW CORTISOL DERIVATIVE. European Journal of Endocrinology. 61(1_Suppl). S87–S87.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Gerold Breakdown of academic impact, for papers by J.R. Boissier Breakdown of academic impact, for papers by Ronald D. Robson Breakdown of academic impact, for papers by F Lefèvre-Borg Breakdown of academic impact, for papers by Charles A. Harrington Breakdown of academic impact, for papers by A. Pinelli Breakdown of academic impact, for papers by Rodolfo Testa Breakdown of academic impact, for papers by Irwin H. Slater Breakdown of academic impact, for papers by H Schmitt Breakdown of academic impact, for papers by G. Kroneberg
Rankless by CCL
2026